Expertise in
9
conditions

Benoit C. Coffin

Neuilly-sur-seine, FR 
Expertise in
9
conditions
Neuilly-sur-seine, FR 

Overview

Benoit Coffin practices practicing medicine in Neuilly-sur-seine, France.

Mr. Coffin is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Gastroparesis, Viral Gastroenteritis, Irritable Bowel Syndrome (IBS), Gastric Bypass, and Endoscopy.

He is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Neuilly-sur-seine, France
Other Locations
Paris, France
Colombes, France
Boulogne-billancourt, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study
USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study
Enrollment Status: Unknown
Publish Date: July 22, 2024
Intervention Type: Drug
Study Drug: Ustekinumab
Study Phase: Phase 4
Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients
Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients
Enrollment Status: Unknown
Publish Date: July 08, 2024
Intervention Type: Drug
Study Drugs: Ramucirumab, Paclitaxel
Study Phase: Phase 2
A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus Infliximab to Corticosteroids Plus Azathioprine for Acute Severe Colitis
A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus Infliximab to Corticosteroids Plus Azathioprine for Acute Severe Colitis
Enrollment Status: Completed
Publish Date: May 31, 2023
Intervention Type: Drug
Study Drugs: Azathioprine, Infliximab, Prednisolone, Hydrocortisone
Study Phase: Phase 4
International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ)
International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ)
Enrollment Status: Completed
Publish Date: February 18, 2019
Intervention Type: Other
Stretta In Reflux Uncontrolled by Intake of Inhibitors of Protons Pump (IPP).- The SIRUP Trial- Multicentric, Randomized, Double Blind, Prospective Study
Stretta In Reflux Uncontrolled by Intake of Inhibitors of Protons Pump (IPP).- The SIRUP Trial- Multicentric, Randomized, Double Blind, Prospective Study
Enrollment Status: Completed
Publish Date: January 29, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

84 Total Publications

One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.
Journal: Alimentary pharmacology & therapeutics
Published: February 17, 2026

Frequently Asked Questions about Benoit C. Coffin

Is Benoit C. Coffin a top-rated expert for Gastroparesis?

MediFind is an objective health platform that identifies experts based on real-world data. Benoit C. Coffin is classified as an Advanced expert for Gastroparesis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Benoit C. Coffin participate in research or clinical trials?

Yes. Benoit C. Coffin has published 84 articles and abstracts on conditions like Gastroparesis. You can view a list of Benoit C. Coffin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Coffin's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile